Overview

Methadone in Post-Herpetic Neuralgia Pain

Status:
Completed
Trial end date:
2013-03-01
Target enrollment:
0
Participant gender:
All
Summary
Neuropathic pain is a common condition and affecting 40 to 70% of the general population. Post-herpetic neuralgia is a condition almost complex and requires a multi modal treatment. Aim: This is a pilot proof-of-principle study designed to evaluate the use of low-dose methadone in post-herpetic neuralgia patients who remained refractory after first and second line treatment for post-herpetic neuralgia (PHN) and had indication for the association of an opioid agent to their current drug regimen.
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
University of Sao Paulo
Treatments:
Methadone
Criteria
Inclusion Criteria:

- Patients with chronic (>6 months) symptomatic PHN

- with visual analogical scale >40/100mm

- use of first and second line drugs (tricyclic antidepressants, venlafaxine and
gabapentinoids)

Exclusion Criteria:

- Don't full the criteria above